{"schema_version":"secwatch.filing_event.v1","accession":"0001803737-23-000050","form_type":"8-K/A","ticker":"EHAB","cik":"0001803737","company_name":"Enhabit, Inc.","filed_at":"2023-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.672398+00:00","generated_at":"2026-06-17T02:05:10.122541+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Enhabit corrects Q4 2022 results: net loss $94.7M, revenue down 4.7% YoY","bullets":["Corrected Q4 2022 net loss of $94.7M ($1.91 loss per diluted share); adjusted EPS $0.17.","Revenue $263.2M, down 4.7% YoY; adjusted EBITDA $30.3M, down 38.2% YoY.","Home health revenue $215.8M (-3.7% YoY); total admissions 50,048 (-1.5% YoY).","Hospice revenue $47.4M (-9.0% YoY); average daily census 3,588 (-1.2% YoY).","FY 2023 guidance: revenue $1.11-1.14B, adj. EBITDA $125-140M, adj. EPS $0.50-0.89."],"urls":{"canonical":"https://secwatch.observer/filing/0001803737-23-000050","json":"https://secwatch.observer/filing/0001803737-23-000050.json","markdown":"https://secwatch.observer/filing/0001803737-23-000050.md","text":"https://secwatch.observer/filing/0001803737-23-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1803737/000180373723000050/0001803737-23-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1803737/000180373723000050/ehab-20230214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T02:05:10.122541+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e20a194eedbea363b03387434beeba3ef392189e","claim":"Enhabit, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $263.2 million, EPS Loss per diluted share of $(1.91). Guidance initiated.","evidence_excerpt":"a local level. While we face numerous headwinds in 2023, we remain confident in the long-term prospects for Enhabit.” SUMMARY PERFORMANCE - CONSOLIDATED • Net service revenue of $263.2 million, declined 4.7% from Q4’21 • Net loss of $(94.7) million, declined 417.8% from Q4’21 • Adjusted EBITDA of $30.3 million, down 38.2% from Q4’21 • Loss per diluted share of $(1.91)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1803737/000180373723000050/0001803737-23-000050-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$263.2 million"},{"label":"EPS","value":"Loss per diluted share of $(1.91)"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}